..

遗传学和 DNA 研究杂志

Evaluating drug-chromatin interactions using novel methods for target engagement studies

Abstract

Marta Rucka

Regulation of gene expression is a dynamic process orchestrated and maintained by a large variety of chromatin-interacting proteins. Understanding these chromatin-protein complexes and their binding kinetics is crucial for development of the small-molecule drugs. Promega has developed NanoBRET technology, which allows for dynamic measurement of protein:protein interactions (PPIs) in living cells.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证

分享此文章

索引于

相关链接

arrow_upward arrow_upward